Peptide Research Profiles
Educational profiles for research peptides — scientific background, published research areas and analytical considerations. No dosing or human-use content.
An educational profile of BPC-157, a synthetic pentadecapeptide derived from a Body Protection Compound sequence originally identified in gastric juice, with an overview of its research context and analytical considerations.
An educational profile of Semax, a synthetic heptapeptide derived from an ACTH(4-10) fragment, with an overview of its research context, neuropeptide background and analytical considerations.
An educational profile of Selank, a synthetic heptapeptide analogue of tuftsin, with an overview of its research context and analytical considerations.
An educational profile of Tesamorelin, a synthetic analogue of growth hormone-releasing factor GRF(1-44), with an overview of its research context and analytical considerations.
A small-molecule research compound investigated as an inhibitor of nicotinamide N-methyltransferase (NNMT), with published preclinical interest in metabolic and adipose-tissue research.
A synthetic modified fragment of the C-terminal region of human growth hormone (hGH 177-191), studied in preclinical lipid-metabolism research.
A long-acting synthetic amylin analogue investigated in metabolic and appetite-regulation research, characterised by a fatty-acid side chain for prolonged half-life.
A synthetic GRF analogue supplied in two forms — with a DAC (drug affinity complex) linker for extended half-life, and without DAC — investigated in growth-hormone-axis preclinical research.
Delta Sleep-Inducing Peptide, a naturally occurring nonapeptide identified in early sleep-neurophysiology research and studied in a range of preclinical contexts.
A synthetic tetrapeptide (Ala-Glu-Asp-Gly), developed from research at the Saint Petersburg Institute of Bioregulation and Gerontology, studied in longevity and cellular-ageing research.
A naturally occurring copper-binding tripeptide (Gly-His-Lys) complexed with copper(II), extensively studied in skin, wound-healing and gene-regulation research.
A synthetic growth-hormone-releasing hexapeptide investigated as a ghrelin-receptor agonist in preclinical growth-hormone-axis research.
A synthetic hexapeptide ghrelin-receptor agonist, one of the earliest characterised growth-hormone-releasing peptides.
A synthetic peptide corresponding to residues 176-191 of the C-terminal region of human growth hormone, investigated in preclinical lipid-metabolism research.
A synthetic pentapeptide ghrelin-receptor agonist studied in growth-hormone-axis research, notable for its selectivity relative to earlier growth-hormone secretagogues.
A branded synthetic peptide blend supplied by Peptovia Research combining multiple research peptides commonly investigated in skin and connective-tissue research contexts.
The C-terminal tripeptide of α-melanocyte-stimulating hormone (Lys-Pro-Val), studied in preclinical inflammation and mucosal-biology research.
The human cathelicidin antimicrobial peptide, a 37-residue amphipathic α-helical peptide studied in innate-immunity, antimicrobial and immunomodulatory research.
A 16-residue mitochondrial-derived peptide encoded within the mitochondrial 12S rRNA gene, studied in preclinical metabolic and cellular-stress research.
A synthetic cyclic α-melanocyte-stimulating hormone analogue investigated in preclinical pigmentation and melanocortin-receptor research.
Nicotinamide adenine dinucleotide, a coenzyme central to cellular metabolism and redox biology, supplied as a research reagent for in-vitro laboratory work.
A naturally occurring cyclic nonapeptide hormone with an extensively characterised role in mammalian reproductive and social-behaviour research.
Bremelanotide, a synthetic cyclic melanocortin-receptor agonist, developed pharmaceutically and studied in preclinical melanocortin-receptor research.
Elamipretide, a synthetic mitochondrial-targeted tetrapeptide investigated in preclinical mitochondrial-dysfunction and cardiolipin research.
A synthetic fragment of Thymosin beta-4 studied in preclinical tissue-repair and actin-binding research.
A naturally occurring 28-residue immunomodulatory peptide extensively studied in preclinical and clinical immunology research.
Vasoactive Intestinal Peptide, a 28-residue neuropeptide with a wide preclinical research literature spanning vascular, immunological and neurological contexts.